SSKI- potassium iodide solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

Potassium Iodide (UNII: 1C4QK22F9J) (Iodide Ion - UNII:09G4I6V86Q)

Available from:

Upsher-Smith Laboratories, LLC

INN (International Name):

Potassium Iodide

Composition:

Potassium Iodide 1 g in 1 mL

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

SSKI® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema. Contraindicated in patients with a known sensitivity to iodides.

Product summary:

SSKI® (potassium iodide oral solution, USP) is supplied in 1 fluid ounce (30 ml) bottles (NDC 0245-0003-31) with a calibrated dropper marked to deliver 0.3 ml (300 mg) and 0.6 ml (600 mg); and 8 fluid ounce (237 ml) bottles (NDC 0245-0003-08). Inactive ingredient: Sodium thiosulfate as a preservative. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Keep tightly closed and protected from light. Dispense in tight, light-resistant containers with child-resistant closures. Notice: When exposed to cold temperatures, crystallization may occur, but on warming and shaking, the crystals will redissolve. If the solution turns brownish-yellow in color, it should be discarded.

Authorization status:

unapproved drug other

Summary of Product characteristics

SSKI- POTASSIUM IODIDE SOLUTION
UPSHER-SMITH LABORATORIES, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
SSKI
POTASSIUM IODIDE ORAL SOLUTION, USP (SATURATED)
1 G/ML
INSERT
DES CRIPTION
SSKI
(potassium iodide oral solution, USP) is a saturated solution of
potassium iodide containing 1
gram of potassium iodide per mL.
CLINICAL PHARMACOLOGY
Potassium iodide is thought to act as an expectorant by increasing
respiratory tract secretions and
thereby decreasing the viscosity of mucus.
INDICATIONS AND USAGE
SSKI
(potassium iodide oral solution, USP) is for use as an expectorant in
the symptomatic treatment
of chronic pulmonary diseases where tenacious mucus complicates the
problem, including bronchial
asthma, bronchitis and pulmonary emphysema.
CONTRAINDICATIONS
Contraindicated in patients with a known sensitivity to iodides.
WARNINGS
Potassium iodide can cause fetal harm, abnormal thyroid function, and
goiter when administered to a
pregnant woman. Because of the possible development of fetal goiter,
if the drug is used during
pregnancy or if the patient becomes pregnant during therapy, apprise
the patient of the potential hazard.
PRECAUTIONS
GENERAL
In some patients, prolonged use of iodides can lead to hypothyroidism.
Iodides should be used with
caution in patients having Addison's disease, cardiac disease,
hyperthyroidism, myotonia congenita,
tuberculosis, acute bronchitis, or renal function impairment.
DRUG INTERACTIONS
Concurrent use with lithium or antithyroid drugs may potentiate the
hypothyroid and goitrogenic effects
of these medications. Concurrent use with potassium-containing
medications, potassium-sparing
diuretics and angiotensin-converting enzyme inhibitors (ACE
inhibitors) may result in hyperkalemia and
cardiac arrhythmias or cardiac arrest.
DRUG/LABORATORY TEST INTERACTIONS
®
®
®
DRUG/LABORATORY TEST INTERACTIONS
Thyroid function tests may be altere